Single-Site Investigator-Initiated Clinical Trials
Funds a single-site clinical trial in heart, lung or blood disease, run through two milestone-gated phases by one team.
NHLBI wants investigator-led clinical trials that answer real questions in heart, lung, blood and sleep disease — and this is the version built for a single site running the whole thing itself.
What qualifies is broad by design: efficacy trials, comparative effectiveness trials, pragmatic trials, and dissemination and implementation science trials, including ones testing prevention strategies alo…
Single-site investigator-initiated clinical trials relevant to NHLBI's research mission — efficacy, comparative effectiveness, pragmatic, and dissemination and implementation science trials, including therapeutic, behavioral and prevention-strategy studies — run as a bi-phasic, milestone-driven award. A clinical trial is required.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up